INNOVATIVE DESIGN ORTHOPAEDICS LIMITEDActive

Company number 06999299Private limited companyIncorporated 2009

Key figures

£446,456+11.1%
Net assets 2025
+52.8%
Average annual growth 2020–2025
0200 k400 k600 k202020212022202320242025

Like most small UK companies, INNOVATIVE DESIGN ORTHOPAEDICS LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0500 k1 m1.5 m202020212022202320242025
Filed accounts2020–2025
20212022202320242025
Cash at bank and in hand49,54965,96613,61924,2587,330
Total assets836,764910,1491,047,5091,154,2101,135,095
Total liabilities797,318————
Net assets / total equity112,383211,530248,228401,773446,456
Average number of employees33434

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: INNOVATIVE DESIGN ORTHOPAEDICS LIMITED

Company

INNOVATIVE DESIGN ORTHOPAEDICS LIMITED is a private limited company registered with Companies House under company number 06999299. It was incorporated on 24 Aug 2009. Its status is active. The registered office is in Reading (RG7). Its nature of business (SIC 2007) is manufacture of medical and dental instruments and supplies (32500), retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. (47749).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files small company accounts (filleted). Net assets were £446,456, up 11.1% on the previous year. Cash at bank and in hand was £7,330. The company had an average of 4 employees. Figures are available for 6 financial years (2020–2025).

Control and charges

One person with significant control is registered. 1 of 1 registered charges are outstanding.

Filing deadlines

The next accounts are due by 30 Sep 2027. The next confirmation statement is due by 7 Sep 2027.